These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Our Best Shot: Texas Physicians Help Find Safe, Effective COVID-19 Vaccines. Price S Tex Med; 2020 Nov; 116(11):16. PubMed ID: 33641131 [TBL] [Abstract][Full Text] [Related]
3. FDA authorizes Johnson & Johnson COVID-19 vaccine. Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088 [No Abstract] [Full Text] [Related]
4. FDA authorizes Pfizer-BioNTech COVID-19 vaccine. Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996 [No Abstract] [Full Text] [Related]
5. FDA authorizes Moderna COVID-19 vaccine. Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345 [No Abstract] [Full Text] [Related]
8. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy. Ortega RodrÃguez NR; AudÃcana Berasategui MT; de la Hoz Caballer B; Valero Santiago A J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485 [No Abstract] [Full Text] [Related]
9. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for children 5-11 years old. Med Lett Drugs Ther; 2021 Nov; 63(1638):185. PubMed ID: 35085214 [No Abstract] [Full Text] [Related]
10. COVAX Statement on WHO emergency use listing for AstraZeneca/Oxford COVID-19 vaccine. Neurosciences (Riyadh); 2021 Apr; 26(2):222-223. PubMed ID: 33814381 [No Abstract] [Full Text] [Related]
11. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development. Kahn JP; Henry LM; Mastroianni AC; Chen WH; Macklin R Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28538-28542. PubMed ID: 33122444 [No Abstract] [Full Text] [Related]
12. Is there a role for childhood vaccination against COVID-19? Eberhardt CS; Siegrist CA Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210 [TBL] [Abstract][Full Text] [Related]
13. How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream. Witek TJ Pharmaceut Med; 2021 Sep; 35(5):287-295. PubMed ID: 34580837 [TBL] [Abstract][Full Text] [Related]
14. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines. Joffe S JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069 [No Abstract] [Full Text] [Related]
15. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations. Krause PR; Gruber MF N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383 [No Abstract] [Full Text] [Related]
16. Global covid-19 vaccine rollout and safety surveillance-how to keep pace. Lo Re V; Klungel OH; Chan KA; Panozzo CA; Zhou W; Winterstein AG BMJ; 2021 Jun; 373():n1416. PubMed ID: 34144957 [No Abstract] [Full Text] [Related]